文献速递先天性心脏病外科

Fontan术后左心发育不良综合征解剖亚型的长期影响

Long-term impact of anatomic subtype in hypoplastic left heart syndrome after Fontan completion.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-11-10

单中心回顾性研究纳入1989年8月至2017年7月在本中心行Fontan术的418例经典左心发育不良综合征(HLHS)患者,中位随访8.6年。20年总体无移植生存率为70.1%,AA/MS亚型生存率较低(17年时AA/MS 56.1% vs AA/MA 74.6% vs AS/MS 79.1%,P=.04),作者认为与单心室衰竭率较高相关。

要点

  • AA/MS亚型Fontan术后长期生存率较低(17年时56.1% vs AA/MA 74.6%、AS/MS 79.1%,P=.04)。
  • 20年总体无移植生存率70.1%,房室瓣失败累积发生率35.9%,心室失败17.9%。
  • AA/MS较AA/MA心室失败率有升高趋势但未达统计学显著(17年时26.2% vs 11.2%,P=.053)。

核心结论

  • AA/MS解剖亚型的生存风险在Fontan完成后长期持续存在,可能源于单心室衰竭率较高而非房室瓣失败。
  • 作者认为AA/MS造成的发育不良左心室异常压力负荷状态对单右心室功能有不利影响。

研究设计与样本

  • 回顾性单中心研究,纳入1989年8月至2017年7月在本中心行Fontan术的经典HLHS患者418例。
  • 亚型分布:AA/MA 153例、AA/MS 100例、AS/MS 154例、AS/MA 11例;采用多变量统计分析评估HLHS亚型的影响。
  • 中位随访8.6年(四分位距2.9-15.8年)。

主要发现

  • 20年总体无移植生存率为70.1%,房室瓣失败累积发生率为35.9%,心室失败累积发生率为17.9%。
  • 17年时生存率:AA/MA 74.6% vs AS/MS 79.1% vs AA/MS 56.1%,P=.04。
  • AA/MA与AA/MS亚组分析:17年时心室失败率AA/MA 11.2% vs AA/MS 26.2%,P=.053;房室瓣失败无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic atresia (AA)/mitral stenosis (MS) is a well-known risk factor for survival after Norwood; however, the effect of anatomical subtypes in those who survive surgical palliation is unknown. METHODS: We performed a retrospective single-center study of patients with classic hypoplastic left heart syndrome (HLHS) who underwent Fontan at our center between August 1989 and July 2017. Clinical outcomes, as well as ventricular and atrioventricular-valve (AVV) function, were determined for each patient, and the effects of HLHS subtype were estimated using multivariable statistical analyses. RESULTS: We included 418 patients with HLHS (AA/mitral atresia [MA] 153, AA/MS 100, aortic stenosis [AS]/MS 154, and AS/MA 11). The median follow-up period was 8.6 (interquartile range, 2.9-15.8) years. Overall transplant-free survival, cumulative incidence of AVV failure, and ventricular failure, which were defined by moderate dysfunction or greater or the necessity of surgical interventions, were 70.1%, 35.9%, and 17.9% at 20 years, respectively. Of the 3 major subtypes, AA/MS was associated with lower survival rate (AA/MA 74.6% vs AS/MS 79.1% vs AA/MS 56.1% at 17 years, P = .04). The subanalysis between AA/MA and AA/MS revealed AA/MS tended to have a greater rate of ventricular failure without a significant difference of AVV failure (AA/MA 11.2% vs AA/MS 26.2% at 17 years, P = .053). CONCLUSIONS: The survival risk of the anatomic subtype AA/MS persisted long term after Fontan completion and was likely due to a greater rate of single ventricle rather than AVV failure. These findings suggest that the abnormal pressure overload condition of the hypoplastic left ventricle created by AA/MS has a detrimental effect on single right ventricle function.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Moon J, Lancaster T, Sood V, et al. Long-term impact of anatomic subtype in hypoplastic left heart syndrome after Fontan completion. J Thorac Cardiovasc Surg. 2023. PMID: 37951533. doi:10.1016/j.jtcvs.2023.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。